Document is current
Any future updates will be listed below
-
Authors
Linder, Johannes http://orcid.org/0000-0003-2134-7292
Koplik, Samantha E. http://orcid.org/0000-0003-3614-4885
Kundaje, Anshul http://orcid.org/0000-0003-3084-2287
Seelig, Georg http://orcid.org/0000-0002-3163-8782
-
Funding
Funding for this research was provided by:
National Institutes of Health (U01HG012069, 5R21HG010945)
National Science Foundation (EF 2021552)
National Science Foundation (DGE-2140004)
- License Information
-
More Information
Article History
Received: 17 May 2022
Accepted: 19 October 2022
First Online: 5 November 2022
Declarations
:
: Not applicable.
: A.K. is a scientific co-founder of Ravel Biotechnology Inc.; is on the SAB of PatchBio Inc., SerImmune Inc., AINovo Inc., TensorBio Inc., and OpenTargets; is a consultant with Illumina Inc.; and owns shares in DeepGenomics Inc., Immuni Inc. and Freenome Inc. G.S. is a co-founder of Parse Biosciences and is on the SAB of Modulus Therapeutics.
